Predictors of anemia in a multi-ethnic chronic kidney disease population: a case–control study

SpringerPlus

Volumn 4, Issue 1, 2015, Pages 1-9

  Lau, Bing Chang Vincent ^a   Ong, Kheng Yong ^a   Yap, Chun Wei ^a   Vathsala, Anantharaman ^b   How, Priscilla ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

Anemia; Chronic kidney disease; Hemoglobin; Iron; Risk factors

Indexed keywords

EID: 84957580258     PISSN: None     EISSN: 21931801     Source Type: Journal    
DOI: 10.1186/s40064-015-1001-z     Document Type: Article

References (42)

1. Al-Khoury S, Afzali B, Shah N, Covic A, Thomas S, Goldsmith DJ (2006) Anemia in diabetic patients with chronic kidney disease – prevalence and predictors. Diabetologia 49:1183–1189
2. Astor BC, Muntner P, Levin A, Eustace JA, Coresh J (2002) Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988–1994). Arch Intern Med 162:1401–1408
3. Basile JN (2007) Clinical considerations and practical recommendations for the primary care practitioner in the management of anemia of chronic kidney disease. South Med J 100:1200–1207
4. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS (2003) Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 41:1–12
5. Cresanta JL, Croft JB, Webber LS, Nicklas TA, Berenson GS (1987) Racial difference in hemoglobin concentration of young adults. Prev Med 16:659–669
6. Denny SD, Kuchibhatla MN, Cohen HJ (2006) Impact of anemia on mortality, cognition, and function in community-dwelling elderly. Am J Med 119:327–334
7. Drüeke TB, Locatelli F, Clyne N, Eckardt KU, Macdougall IC, Tsakiris D, Burger HU, Scherhag A, CREATE Investigators (2006) Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 355:2071–2084
8. FDA Drug Safety Communication (2007) Modified dosing recommendations to improve the safe use of Erythropoiesis-Stimulating Agents (ESAs) in chronic kidney disease., http://www.fda.gov/Drugs/DrugSafety/ucm259639.htm. Accessed 16 October 2013
9. Fishbane S, Singh AK (2009) Iron deficiency in non-dialysis chronic kidney disease. Kidney Int 75:752–754
10. Gilbertson DT, Peng Y, Bradbury B, Ebben JP, Collins AJ (2009) Hemoglobin level variability: anemia management among variability groups. Am J Nephrol 30:491–498
11. Hayashi T, Suzuki A, Shoji T, Togawa M, Okada N, Tsubakihara Y, Imai E, Hori M (2000) Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in predialysis patients with chronic renal failure. Am J Kidney Dis 35:250–256
12. Hsu CY, McCulloch CE, Curhan GC (2002) Epidemiology of anemia associated with chronic renal insufficiency among adults in the United States: results from the Third National Health and Nutrition Examination Survey. J Am Soc Nephrol 13:504–510
13. Incalzi RA, Corsonello A, Pedone C, Battaglia S, Paglino G, Bellia V, Extrapulmonary Consequences of COPD in the Elderly Study Investigators (2010) Chronic renal failure: a neglected comorbidity of COPD. Chest 137:831–837
14. Iseki K, Kohagura K (2007) Anemia as a risk factor for chronic kidney disease. Kidney Int 72:S4–S9
15. KDIGO Anemia Work Group (2012) KDIGO Clinical practice guideline for anemia in chronic kidney disease. Kidney Int Suppl 2:279–335
16. KDIGO Work Group (2013) KDIGO Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 3:1–150
17. Kim SM, Lee CH, Oh YK, Joo KW, Kim YS, Kim S, Lim CS (2011) The effects of oral iron supplementation on the progression of anemia and renal dysfunction in patients with chronic kidney disease. Clin Nephrol 75:472–479
18. London R, Solis A, Goldberg GA, Wade S, Ryu S (2002) Health care resource utilization and the impact of anemia management in patients with chronic kidney disease. Am J Kidney Dis 40:539–548
19. Ly J, Marticorena R, Donnelly S (2004) Red blood cell survival in chronic renal failure. Am J Kidney Dis 44:715–719
20. McClellan W, Aronoff SL, Bolton WK, Hood S, Lorber DL, Tang KL, Tse TF, Wasserman B, Leiserowitz M (2004) The prevalence of anemia in patients with chronic kidney disease. Curr Med Res Opin 20:1501–1510
21. McFarlane SI, Chen SC, Whaley-Connell AT, Sowers JR, Vassalotti JA, Salifu MO, Li S, Wang C, Bakris G, McCullough PA, Collins AJ, Norris KC, Kidney Early Evaluation Program Investigators (2008) Prevalence and associations of anemia of CKD: Kidney early evaluation program (KEEP) and National health and nutrition examination survey (NHANES) 1999–2004. Am J Kidney Dis 51:S46–S55
22. Ministry of Health, Singapore (2013) Statistics, Principal Causes of Death., https://www.moh.gov.sg/content/moh_web/home/statistics/Health_Facts_Singapore/Principal_Causes_of_Death.html Accessed 30 June 2015.
23. Moore E, Bellomo R (2011) Erythropoietin (EPO) in acute kidney injury. Ann Intensive Care 1:3
24. Moreno F, Aracil FJ, Perez R, Valderrabano F (1996) Controlled study on the improvement of quality of life in elderly hemodialysis patients after correcting end-stage renal disease-related anemia with erythropoietin. Am J Kidney Dis 27:548–556
25. Moreno F, Sanz-Guajardo D, Lopez-Gomez JM, Jofre R, Valderrabano F (2000) Increasing the hematocrit has a beneficial effect on quality of life and is safe in selected hemodialysis patients. Spanish Cooperative Renal Patients Quality of Life Study Group of the Spanish Society of Nephrology. J Am Soc Nephrol 11:335–342
26. National Kidney Foundation (2006) K/DOQI Clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. Am J Kidney Dis 47:S1–S145
27. National Registry of Diseases Office, Singapore (2013) Health Fact Sheet: Trends of End Stage Renal Disease in Singapore. Ministry of Health, Singapore., https://www.nrdo.gov.sg/docs/librariesprovider3/Publications---Kidney-Failure/health_factsheet_esrd_2013feb.pdf?sfvrsn=0 Accessed 30 June 2015.
28. Nurko S (2006) Anemia in chronic kidney disease: causes, diagnosis, treatment. Cleve Clin J Med 73:289–297
29. Pan WH, Habicht JP (1991) The non-iron-deficiency-related difference in hemoglobin concentration distribution between blacks and whites and between men and women. Am J Epidemiol 134:1410–1416
30. Pfeffer MA, Burdmann EA, Chen CY, Cooper ME, de Zeeuw D, Eckardt KU, Feyzi JM, Ivanovich P, Kewalramani R, Levey AS, Lewis EF, McGill JB, McMurray JJ, Parfrey P, Parving HH, Remuzzi G, Singh AK, Solomon SD, Toto R, TREAT Investigators (2009) A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med 361:2019–2032
31. Pickett JL, Theberge DC, Brown WS, Schweitzer SU, Nissenson AR (1999) Normalizing hematocrit in dialysis patients improves brain function. Am J Kidney Dis 33:1122–1130
32. Portolés J, Gorriz JL, Rubio E, de Alvaro F, Garcia F, Alvarex-Chivas V, Aranda P, Martinez-Castelao A, NADIR-3 Study Group (2013) The development of anemia is associated to poor prognosis in NKF/KDOQI stage 3 chronic kidney disease. BMC Nephrol 14:2. doi:10.1186/1471-2369-14-2
33. Ramanath V, Gupta D, Jain J, Chaudhary K, Nistala R (2012) Anemia and chronic kidney disease: making sense of the recent trials. Rev Recent Clin Trials 7:187–196
34. Revicki DA, Brown RE, Feeny DH, Henry D, Teehan BP, Rudnick MR, Benz RL (1995) Health-related quality of life associated with recombinant human erythropoietin therapy for predialysis chronic renal disease patients. Am J Kidney Dis 25:548–554
35. Rossert J, Froissart M, Jacquot C (2005) Anemia management and chronic renal failure progression. Kidney Int Suppl 99:S76–S81
36. Ruggenenti P, Schieppati A, Remuzzi G (2001) Progression, remission, regression of chronic renal diseases. Lancet 357:1601–1608
37. Silverberg DS, Wexler D, Iaina A, Schwartz D (2009) The correction of anemia in patients with the combination of chronic kidney disease and congestive heart failure may prevent progression of both conditions. Clin Exp Nephrol 13:101–106
38. Singh AK, Szczech L, Tang KL, Barnhart H, Sapp S, Wolfson M, Reddan D, CHOIR Investigators (2006) Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 355:2085–2098
39. Valderrabano F, Golper T, Muirhead N, Ritz E, Levin A (2001) Chronic kidney disease: why is current management uncoordinated and suboptimal? Nephrol Dial Transplant 16(Suppl 7):61–64
40. Vink G, Frank LE, Pannekoek J (2014) Predictive mean matching imputation of semicontinuous variables. Stat Neerl 68:61–90
41. White IR, Carlin JB (2010) Bias and efficiency of multiple imputation compared with complete-case analysis for missing covariate values. Stat Med 29:2920–2931
42. Wittwer I (2013) Iron deficiency anaemia in chronic kidney disease. J Ren Care 39:182–188